Get started
Massachustocks

$SESN - FDA approval decision on Feb 16

Long
Massachustocks  
NASDAQ:SESN   None
Growth Value NEWS biotech
3
3
growth value news biotech
FDA decision on bladder cancer treatment Vicinium on Feb 16th, 2021. If approved, it's looking like SESN has a shot at breaking the $3.00 mark.

And of course, Massachusetts-based stocks always get a thumbs up from me dawg 👍
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.